ITGB3 and osteosarcoma: Given the previously mentioned connection between differentiation status and radiosensitivity/chemosensitivity, we hypothesize that increased ITGB3 expression may contribute to the resistance of osteosarcoma to radiotherapy and chemotherapy by inhibiting osteogenic differentiation.